NRAGE promotes the malignant phenotype of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a fatal disease, primarily due to the limited effective therapies available for patients with advanced or recurrent stages of the disease. Therefore, in order to improve patient prognosis, it is important to identify an informative biomarker for HCC progression, as...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Lett
Main Authors: SHIMIZU, DAI, KANDA, MITSURO, SUGIMOTO, HIROYUKI, SUEOKA, SATOSHI, TAKAMI, HIDEKI, EZAKA, KAZUHIRO, TANAKA, YURI, HASHIMOTO, RYOJI, OKAMURA, YUKIYASU, IWATA, NAOKI, TANAKA, CHIE, YAMADA, SUGURU, FUJII, TSUTOMU, NAKAYAMA, GORO, KOIKE, MASAHIKO, NOMOTO, SHUJI, FUJIWARA, MICHITAKA, KODERA, YASUHIRO
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2016
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774420/
https://ncbi.nlm.nih.gov/pubmed/26998088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4120
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki